$CYNAF $CTH.V rose 17% today on positive Phase 2 data. $2.75 target. http://t.co/5Vy1M3qBcv http://t.co/v3jMrkb9LH $BSDM $QGEN $GENE $AGEN
Antigenics Inc. is a biotechnology company with immunotherapeutic vaccines in clinical trials in renal carcinoma, melanoma, and gastric and colorectal cancers. The Company's vaccines are based on technology that uses heat shock proteins to modulate the immune system. Antigenics' technology also has applications in infectious diseases and autoimmune disorders.